Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-04-30

FDA Approved: VALSARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Zydus Lifesciences Limited)

View source ↗

Summary

The FDA approved a supplemental application for a valsartan and hydrochlorothiazide generic product from Zydus Lifesciences Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Valsartan and Hydrochlorothiazide (Valsartan and Hydrochlorothiazide)

Snippet

SUPPL AP for VALSARTAN AND HYDROCHLOROTHIAZIDE (VALSARTAN AND HYDROCHLOROTHIAZIDE)